Novo Nordisk A/S (NVO) Stock Chart & Stock Price History $68.17 +1.15 (+1.72%) As of 03:58 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Novo Nordisk A/S Stock Price Performance The Novo Nordisk A/S (NVO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 48.72%, with a year-to-date return of -20.75%. In the past month, the stock has increased 17.56%, reflecting recent market activity. As of the latest close, Novo Nordisk A/S traded at $66.96 with a market cap of $300.49 billion and volume of 11.17 million shares. Five years ago, the stock traded at a split-adjusted price of $16.22, representing a 320.35% increase over that period. At the time, it had a market cap of $154.55 billion and a volume of 8.27 million shares. Receive NVO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Novo Nordisk A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.18%1 Month Performance+17.56%3 Month Performance-18.64%Year-To-Date Performance-20.75%1 Year Performance-48.72%5 Year Performance+320.35% NVO Stock Chart for Tuesday, May, 20, 2025 NVO Chart by TradingView Novo Nordisk A/S Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/20/2025$66.96$68.17+1.81%$70.00$67.6512.55 million shs$305.91 billion05/19/2025$64.35$66.96+4.06%$67.03$64.8711.17 million shs$300.49 billion05/16/2025$66.07$64.35-2.61%$64.70$63.1318.94 million shs$288.75 billion05/15/2025$64.32$66.07+2.72%$66.30$64.789.05 million shs$296.49 billion05/14/2025$65.38$64.32-1.62%$66.83$64.0910.15 million shs$288.64 billion05/13/2025$67.70$65.38-3.42%$66.63$64.9510.34 million shs$293.39 billion05/12/2025$65.75$67.70+2.96%$67.75$64.0418.25 million shs$303.79 billion05/09/2025$64.78$65.75+1.49%$67.44$65.5913.06 million shs$295.06 billion05/08/2025$67.49$64.78-4.02%$65.96$64.4012.02 million shs$290.72 billion05/07/2025$66.32$67.49+1.76%$69.67$66.8214.14 million shs$302.88 billionWashington Is Broke—and Eyeing Your Savings Next (Ad)Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.Get your free guide now by clicking here >>05/06/2025$69.08$66.32-3.99%$68.12$65.9910.49 million shs$297.63 billion05/05/2025$69.27$69.08-0.27%$69.79$68.898.80 million shs$310.00 billion05/02/2025$65.67$69.27+5.48%$69.86$68.5313.45 million shs$310.85 billion05/01/2025$66.53$65.67-1.29%$68.83$64.1816.43 million shs$294.70 billion04/30/2025$65.12$66.53+2.17%$66.64$65.409.24 million shs$298.56 billion04/29/2025$62.61$65.12+4.01%$65.41$64.1610.90 million shs$292.23 billion04/28/2025$62.07$62.61+0.87%$63.25$61.976.28 million shs$280.96 billion04/25/2025$62.59$62.07-0.83%$62.27$60.577.83 million shs$278.54 billion04/24/2025$61.30$62.59+2.11%$62.74$61.847.89 million shs$280.87 billion04/23/2025$59.89$61.30+2.35%$62.43$60.899.07 million shs$275.07 billion04/22/2025$58.37$59.89+2.60%$60.18$58.9211.53 million shs$268.76 billion04/21/2025$57.99$58.37+0.66%$59.30$57.0013.41 million shs$261.94 billion Related Companies Novartis Stock Chart AstraZeneca Stock Chart Sanofi Stock Chart GSK Stock Chart Takeda Pharmaceutical Stock Chart argenx Stock Chart BioNTech Stock Chart Beigene Stock Chart Teva Pharmaceutical Industries Stock Chart Summit Therapeutics Stock Chart Receive NVO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Novo Nordisk A/S and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:NVO) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVO Stock Free NVO Stock Alerts